Teva Says Bayer Can't Amend Claims In Stalled Patent Fight
Teva Pharmaceuticals has argued that rival Bayer can't amend some claims of one of its patents linked to testosterone supplements, claiming that the German pharmaceutical company shouldn't be allowed to introduce...To view the full article, register now.
Already a subscriber? Click here to view full article